Doctor profile · Federal record

Dr. Suthep Arora, M.D.

Infectious Disease Physician (CMS: Infectious Disease) · Infectious Disease Physician · San Antonio, TX

  • NPI 1750564068
  • Accepts Medicare
  • MIPS 51.5 / 100 · 2023
  • 26 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
7940 Floyd Curl Dr Ste 560
San Antonio, TX 782293907
(210) 614-8100
fax (210) 615-7233

Credentials & registration

NPPES · NUCC
NPI registered
December 2007 — 19 yrs on file
Profile last updated
March 24, 2025
Year of graduation
2000 — 26 yrs since
Specialty taxonomy
207RI0200X — NUCC code
State licenses (2)
Texas #N8607 · Indiana #01077805A

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1750564068. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
1,264
Distinct HCPCS
5
Medicare allowed
$126,515
HCPCS Description Services Patients Avg allowed
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 741 177 $75
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes 233 128 $114
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes 229 204 $166
99213 Established patient office or other outpatient visit, 20-29 minutes 35 23 $86
99214 Established patient office or other outpatient visit, 30-39 minutes 26 18 $122

In context: peer comparison

Among 17 peers in San Antonio Infectious Disease Physician, average services per provider: 138. This provider delivers 9.2× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$484
Transactions
27
Manufacturers
10
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 11 $166.64
Melinta Therapeutics, LLC 3 $68.38
Merck Sharp & Dohme LLC 3 $57.53
ViiV Healthcare Company 3 $56.92
Gilead Sciences, INC. 2 $36.58
Shionogi INC 1 $23.65
La Jolla Pharmaceutical Company 1 $23.49
Astellas Pharma US INC 1 $21.08
Aimmune Therapeutics, INC. 1 $16.08
Cumberland Pharmaceuticals, INC. 1 $13.43

By nature of payment

Food and Beverage
$484

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
270
Patients
0
Total drug cost
$615,575
Drug Type Claims Patients Total cost
Biktarvy (Bictegrav/Emtricit/Tenofov Ala) Brand 63 0 $252,390
Tivicay (Dolutegravir Sodium) Brand 27 0 $84,560
Daptomycin Generic 26 0 $25,841
Symtuza (Darunavir/Cob/Emtri/Tenof Alaf) Brand 26 0 $130,230
Ceftriaxone (Ceftriaxone Sodium) Brand 22 0 $1,068
Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) Brand 19 0 $274
Vancomycin Hcl Generic 16 0 $1,302
Prezista (Darunavir) Brand 13 0 $29,326
Ritonavir Generic 13 0 $839
Genvoya (Elviteg/Cob/Emtri/Tenof Alafen) Brand 12 0 $48,731

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Suthep Arora's medical specialty?
Dr. Suthep Arora practices Infectious Disease Physician in San Antonio, TX.
Where does Dr. Suthep Arora practice?
Dr. Suthep Arora practices at 7940 Floyd Curl Dr Ste 560, San Antonio, TX 782293907. Office phone: 2106148100.
What is Dr. Suthep Arora's NPI?
Dr. Suthep Arora's National Provider Identifier (NPI) is 1750564068, issued by NPPES.
Does Dr. Suthep Arora accept Medicare assignment?
Yes. Dr. Suthep Arora accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Suthep Arora commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Initial hospital care with moderate level of medical decision making (HCPCS 99223). Source: CMS Medicare Physician & Other Practitioners file.